Remove Congenital Remove Heart Disease Remove Transplant
article thumbnail

Determinants of survival following heart transplantation in adults with congenital heart disease

Journal of Cardiothoracic Surgery

Adult patients surviving with congenital heart disease (ACHD) is growing. We examine the factors associated with heart transplant outcomes in this challenging population with complex anatomy requiring redo-sur.

article thumbnail

Atlantic Health System’s Morristown Medical Center and NYU Langone Health Expand Partnership to Include Adult Congenital Heart Disease

DAIC

New Jersey-based Atlantic Health System’s Morristown Medical Center and New York-based NYU Langone Health, both nationally recognized cardiovascular programs, have announced that they are expanding their partnership to provide patients improved access to adult congenital heart disease services and the specialist directed care.

article thumbnail

Latest Medical News: Partial Heart Transplant of an Infant

Wellnest

Introduction: Wellnest brings you , the latest medical news where an infant successfully received a partial heart transplant! In a remarkable leap forward for pediatric cardiac care, a groundbreaking partial heart transplant procedure has emerged as a beacon of hope for infants facing severe congenital heart conditions.

article thumbnail

Arrhythmias in children undergoing orthotopic heart transplantation

Frontiers in Cardiovascular Medicine

Introduction Heart transplantation (HT) is the only treatment option in children with heart failure secondary to cardiomyopathies and non-reparable congenital heart diseases.

article thumbnail

A world-class institute dedicated to the treatment of all heart conditions has been inaugurated in Thailand.

Heart 2023 Conference

This institute is dedicated to pioneering research, innovation, and the development of clinically effective techniques for addressing various heart conditions. Additionally, it offers comprehensive cardiac screening and preventive care.

article thumbnail

Waitlist Outcomes in Candidates With Rare Causes of Heart Failure After Implementation of the 2018 French Heart Allocation Scheme

Circulation: Heart Failure

Circulation: Heart Failure, Ahead of Print. BACKGROUND:In 2018, an algorithm-based allocation system for heart transplantation (HT) was implemented in France. The cumulative incidence of waitlist mortality estimated with competing risk analysis and incidence of transplantation were compared between diagnosis groups.

article thumbnail

Lantheus Announces the FDA Approval of DEFINITY as Ultrasound Enhancing Agent for Use in Certain Pediatric Cardiovascular Patients

DAIC

Food and Drug Adminstration (FDA) has approved DEFINITY (Perflutren Lipid Microsphere) as an ultrasound enhancing agent for use in pediatric patients with suboptimal echocardiograms, including those who have undergone heart transplant, or have Kawasaki disease or a congenital cardiovascular anomaly. 5 Kutty, S.,